3rd September 2021 | Pharma Updates
Granules India will make and market DRDO’s 2-DG
The company has recently received a license from DRDO for the same.
MGC Pharma will now import Covid treatment in India
The company has received a license to import its Covid treatment in our country.
Sun Pharma's subsidiary sells its complete shareholding to Shinshin Pharma
Sun Pharma’s Japan unit has sold complete shareholding to Shinshin Pharma for a total amount of JPY 353983400.
DRL, Natco roll out the anti-cancer drug in Canada
Both drugmakers have introduced generic drugs for patients with multiple myeloma and myelodysplastic syndrome in Canada.
Aspen is in dialogue with J & J to market anti-Covid drug
The drugmaker is also looking forward to expanding its vaccine manufacturing from 30 mn doses to 45 mn doses by February of next year.
Sai Life Sciences receives an award from CII
The company’s API unit has received an award for its energy management.
DCGI gives authority to Biological E for the Covid vaccine trial
Biological E’s vaccine for kids clinical trials will be conducted across 10 locations in India.
You must be logged in to post a comment.